1
|
Vychytilova-Faltejskova P, Pesta M, Radova
L, Liska V, Daum O, Kala Z, Svoboda M, Kiss I and Slaby O:
Genome-wide microrna expression profiling in primary tumors and
matched liver metastasis of patients with colorectal cancer. Cancer
Genomics Proteomics. 13:311–316. 2016.PubMed/NCBI
|
2
|
Kopetz S, Chang GJ, Overman MJ, Eng C,
Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM and
McWilliams RR: Improved survival in metastatic colorectal cancer is
associated with adoption of hepatic resection and improved
chemotherapy. J Clin Oncol. 27:3677–3683. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lee H, Flaherty P and Ji HP: Systematic
genomic identification of colorectal cancer genes delineating
advanced from early clinical stage and metastasis. BMC Med
Genomics. 6:542013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Seven M, Karatas OF, Duz MB and Ozen M:
The role of miRNAs in cancer: From pathogenesis to therapeutic
implications. Future Oncol. 10:1027–1048. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Toyota M, Suzuki H, Sasaki Y, Maruyama R,
Imai K, Shinomura Y and Tokino T: Epigenetic silencing of
microRNA-34b/c and B-cell translocation gene 4 is associated with
CpG island methylation in colorectal cancer. Cancer Res.
68:4123–4132. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Hur K, Toiyama Y, Schetter AJ, Okugawa Y,
Harris CC, Boland CR and Goel A: Identification of a
metastasis-specific MicroRNA signature in human colorectal cancer.
J Natl Cancer Inst. 107:pii: dju492. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Huang FJ, Steeg PS, Price JE, Chiu WT,
Chou PC, Xie K, Sawaya R and Huang S: Molecular basis for the
critical role of suppressor of cytokine signaling-1 in melanoma
brain metastasis. Cancer Res. 68:9634–9642. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hamilton SR and Aaltonen LA: Pathology and
genetics of tumours of the digestive system. Histopathology.
38:5852001. View Article : Google Scholar
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally
invasive biomarkers for breast cancer. Ann Surg. 251:499–505. 2010.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Wang J, Chen J, Chang P, LeBlanc A, Li D,
Abbruzzesse JL, Frazier ML, Killary AM and Sen S: MicroRNAs in
plasma of pancreatic ductal adenocarcinoma patients as novel
blood-based biomarkers of disease. Cancer Prev Res (Phila).
2:807–813. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gui J, Tian Y, Wen X, Zhang W, Zhang P,
Gao J, Run W, Tian L, Jia X and Gao Y: Serum microRNA
characterization identifies miR-885-5p as a potential marker for
detecting liver pathologies. Clin Sci (Lond). 120:183–193. 2011.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Afanasyeva EA, Mestdagh P, Kumps C,
Vandesompele J, Ehemann V, Theissen J, Fischer M, Zapatka M, Brors
B, Savelyeva L, et al: MicroRNA miR-885-5p targets CDK2 and MCM5,
activates p53 and inhibits proliferation and survival. Cell Death
Differ. 18:974–984. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Dettmer M, Vogetseder A, Durso MB, Moch H,
Komminoth P, Perren A, Nikiforov YE and Nikiforova MN: MicroRNA
expression array identifies novel diagnostic markers for
conventional and oncocytic follicular thyroid carcinomas. J Clin
Endocrinol Metab. 98:E1–E7. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
23
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
24
|
Spaderna S, Schmalhofer O, Hlubek F, Berx
G, Eger A, Merkel S, Jung A, Kirchner T and Brabletz T: A
transient, EMT-linked loss of basement membranes indicates
metastasis and poor survival in colorectal cancer.
Gastroenterology. 131:830–840. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Yang WH, Su YH, Hsu WH, Wang CC, Arbiser
JL and Yang MH: Imipramine blue halts head and neck cancer invasion
through promoting F-box and leucine-rich repeat protein 14-mediated
Twist1 degradation. Oncogene. 35:2287–2298. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Guaita S, Puig I, Francı́ C, Garrido M,
Domı́nguez D, Batlle E, Sancho E, bDedhar S, De Herreros AG and
Baulida J: Snail induction of epithelial to mesenchymal transition
in tumor cells is accompanied by MUC1 repression and ZEB1
expression. J Biol Chem. 277:39209–39216. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Bellezza I, Neuwirt H, Nemes C, Cavarretta
IT, Puhr M, Steiner H, Minelli A, Bartsch G, Offner F, Hobisch A,
et al: Suppressor of cytokine signaling-3 antagonizes cAMP effects
on proliferation and apoptosis and is expressed in human prostate
cancer. Am J Pathol. 169:2199–2208. 2006. View Article : Google Scholar : PubMed/NCBI
|
28
|
Niwa Y, Kanda H, Shikauchi Y, Saiura A,
Matsubara K, Kitagawa T, Yamamoto J, Kubo T and Yoshikawa H:
Methylation silencing of SOCS-3 promotes cell growth and migration
by enhancing JAK/STAT and FAK signalings in human hepatocellular
carcinoma. Oncogene. 24:6406–6417. 2005. View Article : Google Scholar : PubMed/NCBI
|
29
|
Tan JC and Rabkin R: Suppressors of
cytokine signaling in health and disease. Pediatr Nephrol.
20:567–575. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
He B, You L, Uematsu K, Zang K, Xu Z, Lee
AY, Costello JF, McCormick F and Jablons DM: SOCS-3 is frequently
silenced by hypermethylation and suppresses cell growth in human
lung cancer. Proc Natl Acad Sci USA. 100:14133–14138. 2003.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Weber A, Hengge UR, Bardenheuer W,
Tischoff I, Sommerer F, Markwarth A, Dietz A, Wittekind C and
Tannapfel A: SOCS-3 is frequently methylated in head and neck
squamous cell carcinoma and its precursor lesions and causes growth
inhibition. Oncogene. 24:6699–6708. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yoon S, Yi YS, Kim SS, Kim JH, Park WS and
Nam SW: SOCS5 and SOCS6 have similar expression patterns in normal
and cancer tissues. Tumor Biol. 33:215–221. 2012. View Article : Google Scholar
|
33
|
Fujitake S, Hibi K, Okochi O, Kodera Y,
Ito K, Akiyama S and Nakao A: Aberrant methylation of SOCS-1 was
observed in younger colorectal cancer patients. J Gastroenterol.
39:120–124. 2004. View Article : Google Scholar : PubMed/NCBI
|
34
|
Neuwirt H, Eder IE, Puhr M and Rudnicki M:
SOCS-3 is downregulated in progressive CKD patients and regulates
proliferation in human renal proximal tubule cells in a STAT1/3
independent manner. Lab Invest. 93:123–134. 2013. View Article : Google Scholar : PubMed/NCBI
|